Federal Trade Commission sues largest drug middlemen for
WEB2 days ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Federal Trade Commission accuses three drug middlemen of …
WEB2 days ago · By Mirna Alsharif and Berkeley Lovelace Jr. The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. The FTC accused the "Big ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB2 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB2 days ago · Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while making it harder for patients to obtain...
FTC sues insulin middlemen, saying they pocket billions while …
WEB1 day ago · According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly unaffordable. Over the last two decades, the cost of the lifesaving drug shot up 600% — forcing many Americans with diabetes to ration their medication and jeopardize their health. In 2019, one 1 of 4 insulin patients was unable ...
FTC Accuses Drug Middlemen of Inflating Insulin Prices
WEB2 days ago · The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin. The FTC on Friday filed an ...
Federal Trade Commission to sue drug middlemen over prices of ...
WEBJul 10, 2024 · The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, as the agency argues they...
Health care giant sues to stop antitrust probe of pharmacy drug middlemen
WEB8 hours ago · The owner of one of the three largest pharmacy middlemen in the United States filed suit on Sept. 16 to quash an attempt by the Federal Trade Commission to investigate industry practices.
FTC sues prescription-drug middlemen over insulin prices, says ...
WEB2 days ago · FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’ PBMs owned by CVS, Cigna and UnitedHealth ‘artificially inflated’ prices for lifesaving ...
FTC sues three largest drug middlemen for allegedly inflating …
WEB2 days ago · The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially ...
Skip to content